177Lu-DOTA-TATE

Lutetium-177 DOTATATE · Novartis

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 177Lu-DOTA-TATE, covering 2019-09-30 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours [Phase 1]